Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Reactivation of the latent virus at the dorsal nerve roots and ganglia in patients with chickenpox history may result in quite painful, itchy, and blistering rash on a limited area of the sensory nerve and this condition is called Herpes Zoster or Zona. Herpes Zoster may resolve spontaneously in one or two weeks or course of disease may also be serious in elderly and immunocompromised individuals. Although providing an effective treatment is not always possible, sympathetic nerve block, antiviral agents, analgesics, and opioid drugs might be used. We believe that, sympathetic nerve blocks, with their inhibitory effects on the formation of the post-herpetic neuralgia, are one of the effective treatment modalities especially in patients with insufficient improvement after medications. In this case report, we aimed to present the use of interscalene brachial plexus nerve block to treat a patient with Herpes Zoster in the shoulder area. Key Words: Herpes Zoster; Bupivacaine; Brachial Plexus. Herpes Zosterli Hastada İnterskalen Blok UygulanmasıÖzet Daha önceden suçiçeği geçirmiş kişilerde arka sinir köklerinde ve ganglionlarda latent haldeki virüsün reaktivasyonu sonucu, ilgili sinirin duyusal alanıyla sınırlı, oldukça ağrılı ve kaşıntılı, vezikülo-büllöz döküntülü lezyonlarla karakterize tabloya Herpes Zoster veya Zona denilir. Herpes Zoster bir veya iki haftada kendiliğinden düzelebileceği gibi, özellikle yaşlılarda ve immün sistemi baskılanmış kişilerde ciddi seyredebilir. Herpes Zoster tedavisi kolay olmayıp her zaman etkin şekilde sağlanamamakla beraber, sempatik sinir bloğu, antiviral, analjezik ve opioid gibi ilaçlar kullanılabilmektedir. Özellikle ilaç tedavisinden yeterince fayda görmeyen hastalarda, meydana gelebilecek Postherpetik Nevralji oluşumunu önleyici etkileri de göz önüne alındığında sempatik sinir bloğu uygulaması etkin bir tedavi yöntemi olarak kullanılabileceği kanısındayız. Bu olgu sunusunda, omuz bölgesinde Herpes Zoster tutulumu olan hastanın interskalen blok ile tedavisini sunmayı amaçladık. Anahtar Kelimeler: Herpes Zoster; Bupivakain; Brakiyal Pleksus.Herpes Zoster (HZ) or shingles is the clinical picture in which the latent virus in the dorsal root ganglia is reactivated in people infected with Varicella-Zoster (VZ) chickenpox, especially in adults (1). HZ is characterised by quite painful vesiculobullous rash lesions limited to the right or left of the body and its incidence in the population is between 2,2% and 3,4% (2). The risk of HZ is 10-25% among adults with 95% VZ seropositivity and 50% of these patients are above 85 years of age (3).The following conditions which weaken the immune system, especially in elderly, increase the risk of HZ: organ transplantation, human immunodeficiency virus infection, malignant disease history, diabetes, chemotherapy and radiation therapy and chronic use of corticosteroids (3, 4).While antiviral, non-steroidal anti-inflammatory (NSAID), and opioid medications can be used in acute HZ treatment, sympathetic nerve block applications in the area ...
Reactivation of the latent virus at the dorsal nerve roots and ganglia in patients with chickenpox history may result in quite painful, itchy, and blistering rash on a limited area of the sensory nerve and this condition is called Herpes Zoster or Zona. Herpes Zoster may resolve spontaneously in one or two weeks or course of disease may also be serious in elderly and immunocompromised individuals. Although providing an effective treatment is not always possible, sympathetic nerve block, antiviral agents, analgesics, and opioid drugs might be used. We believe that, sympathetic nerve blocks, with their inhibitory effects on the formation of the post-herpetic neuralgia, are one of the effective treatment modalities especially in patients with insufficient improvement after medications. In this case report, we aimed to present the use of interscalene brachial plexus nerve block to treat a patient with Herpes Zoster in the shoulder area. Key Words: Herpes Zoster; Bupivacaine; Brachial Plexus. Herpes Zosterli Hastada İnterskalen Blok UygulanmasıÖzet Daha önceden suçiçeği geçirmiş kişilerde arka sinir köklerinde ve ganglionlarda latent haldeki virüsün reaktivasyonu sonucu, ilgili sinirin duyusal alanıyla sınırlı, oldukça ağrılı ve kaşıntılı, vezikülo-büllöz döküntülü lezyonlarla karakterize tabloya Herpes Zoster veya Zona denilir. Herpes Zoster bir veya iki haftada kendiliğinden düzelebileceği gibi, özellikle yaşlılarda ve immün sistemi baskılanmış kişilerde ciddi seyredebilir. Herpes Zoster tedavisi kolay olmayıp her zaman etkin şekilde sağlanamamakla beraber, sempatik sinir bloğu, antiviral, analjezik ve opioid gibi ilaçlar kullanılabilmektedir. Özellikle ilaç tedavisinden yeterince fayda görmeyen hastalarda, meydana gelebilecek Postherpetik Nevralji oluşumunu önleyici etkileri de göz önüne alındığında sempatik sinir bloğu uygulaması etkin bir tedavi yöntemi olarak kullanılabileceği kanısındayız. Bu olgu sunusunda, omuz bölgesinde Herpes Zoster tutulumu olan hastanın interskalen blok ile tedavisini sunmayı amaçladık. Anahtar Kelimeler: Herpes Zoster; Bupivakain; Brakiyal Pleksus.Herpes Zoster (HZ) or shingles is the clinical picture in which the latent virus in the dorsal root ganglia is reactivated in people infected with Varicella-Zoster (VZ) chickenpox, especially in adults (1). HZ is characterised by quite painful vesiculobullous rash lesions limited to the right or left of the body and its incidence in the population is between 2,2% and 3,4% (2). The risk of HZ is 10-25% among adults with 95% VZ seropositivity and 50% of these patients are above 85 years of age (3).The following conditions which weaken the immune system, especially in elderly, increase the risk of HZ: organ transplantation, human immunodeficiency virus infection, malignant disease history, diabetes, chemotherapy and radiation therapy and chronic use of corticosteroids (3, 4).While antiviral, non-steroidal anti-inflammatory (NSAID), and opioid medications can be used in acute HZ treatment, sympathetic nerve block applications in the area ...
It may be concluded that SNBs may still be considered useful in PHN management, as it appears that in some cases this mode of treatment may offer some advantages over 5% LMP.
Shingles (herpes zoster) is a painful manifestation of infection of the dorsal root ganglia of the spine and seen as blisters or vesicles in linear formation, usually on the upper torso. Up to one-third of those afflicted will experience complications, with the most common complication being postherpetic neuralgia (PHN). The risk of PHN increases for each decade of life after age 50 years, and the pain associated with this complication has the potential to endure for years, be unrelenting, and decrease an individual's quality of life. Treatment options, including adjunct interventional procedures, are presented to address the common complication of PHN. Although no conclusive evidence base is present for the use of any particular interventional procedure in the treatment of acute pain or refractory pain of shingles, a number of therapies have been indicated to have some level of effectiveness. Standard therapy options in the form of oral medications and topical agents should be used first. For those situations of refractory pain, a referral to an interventional pain management specialist is warranted to explore possible adjunct procedures to lessen the pain of PHN. A comprehensive care management approach, incorporating interventional pain management procedures as an adjunct therapy, will enable patients to have their pain treated as effectively as possible by utilizing appropriate methods available.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.